YBX1 and breast cancer: Next, we interrogated the BC KM-Plotter (https://kmplot.com/analysis, accessed on 6 January 2021) cohort, which contains clinical information on ~5000 BC patients, including 405 TNBCs, and this showed a very significant (p = 1.9 × 108), positive correlation between YB1 mRNA expression and reduced survival probability (Figure 1C, upper panel).